Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Pyxis Oncology Inc (PYXS)

Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review FinancialNewsMedia - Fri Oct 13, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:PYXS),(NASDAQ:AZN),(NYSE:LLY),(NASDAQ:MRUS) EQNX::TICKER_END

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
PYXS : 4.15 (-0.48%)
AZN : 76.90 (-0.18%)
LLY : 770.00 (-0.15%)
MRUS : 43.91 (-2.47%)
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review PR Newswire - Fri Oct 13, 2023

/PRNewswire/ -- USA News Group - Since September 2022, the US Food and Drug Administration (FDA) has seen new treatments for pancreatic cancer that are worthy...

ONC.TO : 1.51 (-2.58%)
ONCY : 1.1100 (-1.77%)
PYXS : 4.15 (-0.48%)
AZN : 76.90 (-0.18%)
LLY : 770.00 (-0.15%)
MRUS : 43.91 (-2.47%)
Breakthroughs in Pancreatic Cancer Treatment: How FDA Designations are Changing the Game BayStreet.ca - Wed Oct 11, 2023

USA News Group – Since September 2022, the US Food and Drug Administration (FDA) has seen new treatments for pancreatic cancer that are worthy of further investigation or approval. Known as one of the...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
PYXS : 4.15 (-0.48%)
AZN : 76.90 (-0.18%)
LLY : 770.00 (-0.15%)
MRUS : 43.91 (-2.47%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ: PYXS) PR Newswire - Thu Sep 21, 2023

/PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Pyxis Oncology, Inc. (NASDAQ: PYXS) concerning possible breaches of...

PYXS : 4.15 (-0.48%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ: PYXS) PR Newswire - Thu Jun 15, 2023

/PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Pyxis Oncology, Inc. (NASDAQ: PYXS) concerning possible breaches of...

PYXS : 4.15 (-0.48%)
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Tue Jul 12, 2022

CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation...

PYXS : 4.15 (-0.48%)
NIRI Chicago Elects 2022-2023 Officers and Directors Business Wire - Wed Jun 29, 2022

The Chicago Chapter of the National Investor Relations Institute (NIRI Chicago) has elected 12 officers and directors to its board for the 2022-2023 term, effective July 1.

UNVR : 36.14 (+0.47%)
WEBR : 8.12 (unch)
PTLO : 10.57 (-3.21%)
MEI : 12.35 (+0.65%)
ACCO : 5.15 (-0.39%)
ZBRA : 317.89 (-0.62%)
BY : 23.99 (+0.84%)
GCMG : 9.96 (+1.01%)
HZNP : 116.30 (+0.04%)
CF : 76.22 (-1.42%)
CTSO : 0.9676 (+11.69%)
PYXS : 4.15 (-0.48%)
Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference Globe Newswire - Tue Jun 28, 2022

CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation...

PYXS : 4.15 (-0.48%)
Pyxis Oncology Announces Presentations at Upcoming Investor Conferences Globe Newswire - Thu May 19, 2022

CAMBRIDGE, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset multi-modality company focused on developing...

PYXS : 4.15 (-0.48%)
Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update Globe Newswire - Fri May 13, 2022

CAMBRIDGE, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset multi-modality company focused on developing...

PYXS : 4.15 (-0.48%)

Barchart Exclusives

3 Cheapest Dividend Kings To Buy Today Barchart - Fri May 17, 6:00PM CDT
This article covers three buy-rated companies that've increased their dividends for 50+ consecutive years. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot